Aptevo Therapeutics (APVO) Competitors $2.77 -0.18 (-6.10%) Closing price 03/5/2025 03:59 PM EasternExtended Trading$2.78 +0.02 (+0.54%) As of 03/5/2025 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends APVO vs. COCP, SNTI, CARM, LPTX, BCAB, GLYC, MEIP, SPRB, MRKR, and MIRAShould you be buying Aptevo Therapeutics stock or one of its competitors? The main competitors of Aptevo Therapeutics include Cocrystal Pharma (COCP), Senti Biosciences (SNTI), Carisma Therapeutics (CARM), Leap Therapeutics (LPTX), BioAtla (BCAB), GlycoMimetics (GLYC), MEI Pharma (MEIP), Spruce Biosciences (SPRB), Marker Therapeutics (MRKR), and MIRA Pharmaceuticals (MIRA). These companies are all part of the "pharmaceutical products" industry. Aptevo Therapeutics vs. Cocrystal Pharma Senti Biosciences Carisma Therapeutics Leap Therapeutics BioAtla GlycoMimetics MEI Pharma Spruce Biosciences Marker Therapeutics MIRA Pharmaceuticals Aptevo Therapeutics (NASDAQ:APVO) and Cocrystal Pharma (NASDAQ:COCP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, community ranking, dividends, profitability and institutional ownership. Is APVO or COCP more profitable? Cocrystal Pharma's return on equity of -94.62% beat Aptevo Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Aptevo TherapeuticsN/A -488.93% -152.51% Cocrystal Pharma N/A -94.62%-78.24% Do institutionals and insiders believe in APVO or COCP? 8.1% of Aptevo Therapeutics shares are held by institutional investors. Comparatively, 6.7% of Cocrystal Pharma shares are held by institutional investors. 0.1% of Aptevo Therapeutics shares are held by company insiders. Comparatively, 25.6% of Cocrystal Pharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, APVO or COCP? Aptevo Therapeutics has a beta of 5.24, meaning that its stock price is 424% more volatile than the S&P 500. Comparatively, Cocrystal Pharma has a beta of 1.54, meaning that its stock price is 54% more volatile than the S&P 500. Which has better valuation & earnings, APVO or COCP? Cocrystal Pharma has lower revenue, but higher earnings than Aptevo Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptevo Therapeutics$3.11M1.30-$24.13MN/AN/ACocrystal PharmaN/AN/A-$17.98M-$1.85-0.93 Does the media prefer APVO or COCP? In the previous week, Aptevo Therapeutics had 1 more articles in the media than Cocrystal Pharma. MarketBeat recorded 2 mentions for Aptevo Therapeutics and 1 mentions for Cocrystal Pharma. Cocrystal Pharma's average media sentiment score of 1.44 beat Aptevo Therapeutics' score of 0.96 indicating that Cocrystal Pharma is being referred to more favorably in the news media. Company Overall Sentiment Aptevo Therapeutics Positive Cocrystal Pharma Positive Does the MarketBeat Community favor APVO or COCP? Aptevo Therapeutics received 175 more outperform votes than Cocrystal Pharma when rated by MarketBeat users. However, 77.42% of users gave Cocrystal Pharma an outperform vote while only 50.13% of users gave Aptevo Therapeutics an outperform vote. CompanyUnderperformOutperformAptevo TherapeuticsOutperform Votes19950.13% Underperform Votes19849.87% Cocrystal PharmaOutperform Votes2477.42% Underperform Votes722.58% Do analysts recommend APVO or COCP? Aptevo Therapeutics currently has a consensus price target of $10,952.00, suggesting a potential upside of 395,279.06%. Cocrystal Pharma has a consensus price target of $7.00, suggesting a potential upside of 306.98%. Given Aptevo Therapeutics' higher possible upside, research analysts clearly believe Aptevo Therapeutics is more favorable than Cocrystal Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aptevo Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Cocrystal Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAptevo Therapeutics and Cocrystal Pharma tied by winning 6 of the 12 factors compared between the two stocks. Get Aptevo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APVO vs. The Competition Export to ExcelMetricAptevo TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.04M$7.28B$5.86B$8.48BDividend YieldN/A2.78%4.89%3.98%P/E RatioN/A6.1925.1719.37Price / Sales1.30225.94387.71116.92Price / CashN/A65.6738.0534.62Price / Book0.856.537.364.33Net Income-$24.13M$138.98M$3.18B$246.62M7 Day Performance-15.81%-1.64%-2.20%-3.05%1 Month Performance-32.60%-8.91%-6.88%-6.50%1 Year Performance-99.96%-11.39%14.29%5.95% Aptevo Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APVOAptevo Therapeutics3.3806 of 5 stars$2.77-6.1%$10,952.00+395,279.1%-100.0%$4.04M$3.11M0.0050COCPCocrystal Pharma3.5507 of 5 stars$1.83-6.2%$7.00+282.5%+11.0%$18.61MN/A-0.9910Short Interest ↓Gap DownSNTISenti Biosciences3.591 of 5 stars$3.85-2.8%$10.00+159.7%-18.9%$18.56M$2.56M-0.254Gap UpCARMCarisma Therapeutics4.063 of 5 stars$0.44-1.8%$4.94+1,017.6%-84.6%$18.45M$14.92M-0.2820Short Interest ↓Gap UpLPTXLeap Therapeutics2.71 of 5 stars$0.48+0.2%$4.92+922.2%-83.5%$18.43MN/A-0.2540Positive NewsBCABBioAtla3.4235 of 5 stars$0.38-6.8%$6.00+1,478.1%-87.4%$18.38MN/A-0.2260Short Interest ↓Gap UpGLYCGlycoMimetics3.7591 of 5 stars$0.28-4.8%$8.00+2,751.0%-90.8%$18.10M$10,000.000.0050News CoverageMEIPMEI Pharma4.4647 of 5 stars$2.65+1.9%$7.00+164.2%-38.9%$17.66M$65.30M-0.46100Short Interest ↓SPRBSpruce Biosciences3.1878 of 5 stars$0.41-1.7%$2.38+475.1%-92.6%$17.06M$10.09M-0.4420Upcoming EarningsGap UpMRKRMarker Therapeutics4.5829 of 5 stars$1.58+0.6%$19.00+1,102.5%-53.7%$16.92M$3.31M0.0060Analyst ForecastNews CoveragePositive NewsGap UpMIRAMIRA Pharmaceuticals2.2243 of 5 stars$1.02-7.3%$14.00+1,272.5%+8.6%$16.89MN/A-1.822Short Interest ↑ Related Companies and Tools Related Companies COCP Alternatives SNTI Alternatives CARM Alternatives LPTX Alternatives BCAB Alternatives GLYC Alternatives MEIP Alternatives SPRB Alternatives MRKR Alternatives MIRA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:APVO) was last updated on 3/6/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | Sponsored77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTrillion-Dollar Crypto PlayAI is Creating Fortunes… (but not where you think!) Bryce Paul and the team at Crypto101 just released a br...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptevo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APVO Stock Alerts